STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $310,000 | -15.1% | 36,208 | +6.0% | 0.01% | -16.7% |
Q4 2016 | $365,000 | +162.6% | 34,153 | +166.9% | 0.01% | +200.0% |
Q3 2016 | $139,000 | +101.4% | 12,796 | +26.3% | 0.00% | +100.0% |
Q2 2016 | $69,000 | -26.6% | 10,133 | -50.0% | 0.00% | +100.0% |
Q1 2016 | $94,000 | +44.6% | 20,266 | +97.2% | 0.00% | -50.0% |
Q4 2015 | $65,000 | -45.8% | 10,275 | -24.7% | 0.00% | -33.3% |
Q3 2015 | $120,000 | -25.5% | 13,641 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $161,000 | -18.3% | 13,641 | 0.0% | 0.00% | -25.0% |
Q1 2015 | $197,000 | -9.6% | 13,641 | +6.8% | 0.00% | -20.0% |
Q4 2014 | $218,000 | +24.6% | 12,771 | -9.0% | 0.01% | 0.0% |
Q3 2014 | $175,000 | – | 14,028 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |